Related Experiment Videos
Sequential changes in AMPA and NMDA protein levels during Fe(3+)-induced epileptogenesis
1Miyazaki Medical College, Department of Psychiatry, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.
Brain Research. Molecular Brain Research
|August 3, 2001
Summary
Epileptogenesis involves changes in glutamate receptor subunits. Early stages show increased AMPA/NMDA receptors, while chronic seizures lead to decreased GluR1/NMDAR1&2A/B and increased GluR2, possibly as a compensatory mechanism.
Area of Science:
- Neuroscience
- Neurobiology
- Epilepsy Research
Background:
- Seizure susceptibility is linked to altered glutamatergic synaptic transmission.
- Ionotropic glutamate receptor expression changes are implicated in epileptogenesis.
Purpose of the Study:
- To investigate the dynamic changes in AMPA and NMDA receptor subunit expression during epileptogenesis.
- To correlate these changes with acute and chronic seizure phases.
Main Methods:
- Western blot analysis was used to quantify receptor subunit levels.
- Hippocampal tissue from both ipsilateral and contralateral sides was analyzed at various time points post-amygdalar FeCl(3) injection.
Main Results:
- Acute phase (+5 days): Significant increases (2-4x baseline) in GluR1, NMDAR1, and NMDAR2 subunits observed in both hippocampi.
- Chronic phase (+15 and +30 days): GluR2 levels increased, while GluR1 and NMDAR1&2A/B levels decreased.
- Early increases in NMDAR1&2A/B suggest upregulation of NMDA receptor production.
Conclusions:
- Early epileptogenesis involves NMDA receptor upregulation.
- Increased GluR2 expression during chronic seizures may be a compensatory mechanism to reduce calcium influx.
- These findings offer insights into the molecular adaptations during seizure development and progression.